Why Do Many Tobacco Science Accounts Look Professional but Can't Make Money? Common Reasons Analyzed
March 2024, in a shared office in Hangzhou Binjiang, I helped a tobacco health account do a "monthly review". Douyin backend views were decent: nearly 2.8 million views in 30 days, completion rate was acceptable for the category, 62,000 followers. Content quality was visible — citing literature, drawing mechanism diagrams, explaining nicotine and dopamine, analyzing "how long after quitting do lungs recover". The host had a medical background, steady delivery, comments often praised "clearer than many doctors".
Then I opened the product and private domain data: 17 orders in 30 days from the storefront, average order value about 89 yuan; 43 new WeChat business contacts, 2 consultation conversions; Knowledge Planet (they tried it for two months) net increase of 11 people, monthly fee 99 yuan, 4 unsubscribes. All told, a team of two plus a part-time editor made a net content-related income of around four figures that month — not enough for one person's social insurance.
That night's review meeting ran until 11 PM. The host kept asking the same question: "We're already professional enough, so why isn't the money coming in?"
My answer was not flattering: Professionalism solves "whether what you say is correct", while making money solves "who is willing to pay for what under what circumstances". Tobacco science accounts most easily build a beautiful bridge between these two things, only to discover that the two ends aren't even on the same river.
Below I break it down by positioning, conversion path, and product design. Not an encyclopedia of pros and cons, but traps I've seen and fallen into myself over the years.
I. Positioning: You Think You're Helping "People Who Want to Quit", but You're Actually Nurturing "People Who Like Watching Health Content"
1. The Most Common Positioning Drift for Professional Accounts
The tobacco track has a hidden trap: the more your content resembles a textbook, the more algorithms and user feedback push you toward the general health-interested crowd, rather than the quit-motivated decision-making crowd.
In November 2023, I worked on a Xiaohongshu account focused on "smoking and oral health". In the first three months, average bookmark rate was 8%–12%, which looked healthy. We analyzed 200 top comments and found high-frequency phrases: "Learned something new", "Forwarding to my husband", "I never knew smoke was this bad for teeth". Those actually saying "I'm on day X of quitting, need methods/products" were less than 15%.
High bookmarks, low conversions — essentially users treat you as a documentary channel, not a solution provider.
Tobacco science is especially prone to this because:
Many people have smoked for over 10 years and already know "smoking is harmful". You explain oxidative stress at the cellular level again — they like it and keep smoking. They're consuming anxiety relief and moral correctness, not a purchase commitment.
2. My View: Tobacco Account Positioning Should Describe "State", Not Just "Topic"
Topic positioning: "Explaining tobacco harm and quitting knowledge."
State positioning: "Serving people who have already decided to quit / are struggling with withdrawal discomfort / are restarting after relapse, providing pathways and tools in the 7–90 day critical window."
The difference is huge.
The former has infinite content universe: history, ingredients, diseases, policies, e-cigarette debates... the more professional, the more scattered.
The latter has clear content boundaries: how to handle withdrawal, what to do when cravings hit, relapse triggers, replacement strategies, how to evaluate NRT suitability, how to coordinate with family.
In June 2024, we changed the oral account's content matrix from "70% harm science + 30% methods" to "60% methods and process + 25% harm as evidence chain + 15% product usage scenarios". Specific changes:
Two months later, private domain consultations roughly doubled. Views actually dropped a bit — less curiosity and scare traffic — but the density of paying users went up.
Clear view: tobacco science accounts can't make money — the first cut is often not "not professional enough", but "professionalism serving the wrong audience state". You're serving the curiosity of onlookers, not the pain timeline of the person going through it.
3. Compliance and Category Sensitivity Further Distort Positioning
Tobacco, quit-smoking aids, and nicotine-related content face different review standards across platforms. In 2024, many accounts made their copy more "purely scientific, no direction" to pass review, resulting in vague positioning: unable to clearly state who you help, how, and to what result.
I've seen accounts change "quit-smoking tool reviews" to "healthy lifestyle sharing" to avoid review, then drift into a generic health account after three months, leaving advertisers confused. Passing review is a survival issue, but you can't trade "focus" for "safety". A more stable approach: public layer does mechanism and behavior management, conversion layer (private domain, detail pages, compliant products) completes the solution loop — instead of blurring the whole account into "correct nonsense".
II. Conversion Path: Trust Accumulated, But No Transaction Design
1. "Professional" Easily Brings False Security
In knowledge payment and self-media monetization, a repeatedly proven reality: traffic and income are not proportional; without a product loop and path design, professional content becomes expensive charity. The industry also commonly sees "subscription loss when charging" — users assume you should always be free with authority, and when a price appears, the psychological contract breaks.
Tobacco science is more acute: users are extremely sensitive to "being harvested". Yesterday you talked about tar causing cancer, today you list a 199 yuan course or device — comments immediately say "another seller". So many hosts choose to never sell, or sell with guilt — listing products but not mentioning them in speech, hiding the link where nobody clicks.
In August 2023, a WeChat Video Account tried selling a 49 yuan "21-Day Quit Smoking Behavior Record + Audio". First week results:
The host panicked and removed all links the next day. I asked him: of the 900 unfollows, had any paid in the past 90 days? Cross-checked the data — almost zero. What you're afraid of losing was never your buyers.
The conversion path must accept a fact: monetization screens people. The question isn't "will I lose followers", but "after the loss, do the remaining people have a clearer purchase path?"
2. Tobacco Users' Decision Chain Is Longer Than Beauty, More Twisted Than Anxiety
Typical wrong path:
Viral harm video → Follow → Continue watching harm → (Expect him to buy from you someday)
The reality is closer to:
Some body signal/family pressure → Search "how to quit" → Scared by fear content and give up → Try again months later → Needs low-friction next step (plan, replacement, community supervision, tools) → May still relapse → Re-enter loop
So your conversion shouldn't be designed as "watch 50 science posts then buy", but as when the window appears, enable a low-risk attempt within 48 hours.
In January 2024, I designed a four-step path for a Douyin account — simple but effective:
1. Public domain: Cover only one specific problem (e.g., "why does coughing get worse two weeks after quitting"), half evidence + half behavior advice;
2. Hook: Pinned comment/subtitle offers "Withdrawal Discomfort Checklist (Free)", deliver via survey or WeCom auto-reply;
3. Private domain 72 hours: Three-step message — confirm quit day count → identify the most painful symptom → offer one option (behavioral method / consultation / compliant product), no bombardment;
4. Conversion: First sell "low-price verifiable" (info pack, 7-day check-in camp, trial size), then upsell to higher ticket, not starting with 999 quit camp.
At the time, free material to friend-add conversion was about 18%–22% (depending on content); within 7 days of adding, 8%–12% showed clear product interest. Not stunning numbers, but much more stable than "storefront only, no private domain action".
3. Three Specific Traps in Conversion Path
Trap A: Treating likes as intent.
Tobacco topics have high emotional engagement. Someone comments "my dad has smoked 30 years" — they may be a filial audience member, the decision-maker isn't them, and the budget and pain aren't on them. You need to distinguish "quitting for self / helping family quit" in the path. The latter is better for content spread, the former is the conversion main force. We once changed the first form question to "Are you quitting for yourself or helping family?" — private domain scripts immediately forked, useless communication dropped significantly.
Trap B: Public domain sales only, no trust progression.
Health-related purchases, especially involving physical intervention, require users to feel "you understand what I'm going through". Pure storefront conversion is poor, not a price issue, but the scene isn't connected. The right approach is to first address their current symptoms in the content, then introduce the tool — not a 5-second end-card "check the cart if you like it".
Trap C: Fear of conversion language, breaking the path.
I've seen account bios say "dedicated to tobacco science, no recommendations, no sales" while privately pushing products — this is the most trust-destroying. Either publicly state "we do quit methods and tool reviews/assistance", or genuinely don't sell. Shifty commercialization loses more followers than honest commercialization, because users feel deceived.
Some in the industry use paid traffic to amplify content, but for initial data, test small first, then scale; if the tobacco content's own conversion model hasn't been proven, paid traffic only magnifies losses. First run a small positive curve of "click → follow → purchase" under organic traffic, then talk about scaling.
III. Product Design: Selling "Correct Knowledge", Users Need "Getting Through Tonight"
1. Professional Accounts' Products Often Take the Wrong Shape
Common product forms:
After 2022, the knowledge payment market grew large, but chaos and refund difficulties made users more cautious: too many watered-down, homogenized, mismatched courses. Making another "Harm Encyclopedia" has near-zero differentiation — free ones online are more complete.
My core view: quit-smoking users pay for results and process relief, rarely for "knowing more about tobacco".
"Knowing more" is your means of building authority, not the product itself.
In May 2024, we canceled a team's two-month prepared "Tobacco Science 20 Lectures" (priced 199) and replaced it with three narrower products:
|---------|-------|------------------------|----------------------|
| "72-Hour Relapse Self-Rescue Checklist" Audio+List | 19.9 | What to do when relapse impulse hits | Repurchase/referral notable, almost no negative reviews |
|---|---|---|---|
| One-on-One 30-Minute Path Review | 199 | Help user choose behavioral method/replacement strategy combination | Best associated sales after consultation |
When the long course was removed, some team members felt it "wasn't professional enough". I asked back: Does professionalism show in the thickness of the table of contents, or in whether the user relapses one less time? Product design that serves the creator's professional ego, rather than the user's critical struggle, is destined to be acclaimed but not bought.
2. Product Design Must Match "Time Granularity"
Quitting smoking isn't like learning photography. Photography can be studied for three months before producing results; quitting failure often happens:
So the product's time granularity should be minute-level, scene-level, not semester-level.
Actionable design principles:
1. One product promises only one stage: e.g., "First 72 hours", "First week", "Social situations without breaking" — don't write "Guaranteed to quit completely".
2. Deliverable must be usable immediately: checklist, scripts (how to respond when offered a cigarette), replacement actions, tracking sheets, when to seek medical advice — fewer "concept chapters".
3. Put "professional" at the evidence layer, "usable" at the interaction layer: you can use guidelines and literature as backing, but the first screen of the payment page should be "What day are you on + What you do tonight".
4. Reserve compliance and boundaries: no efficacy claims, no replacement of medical advice, no non-compliant promotional copy in detail pages. Tobacco-related auxiliary products especially need to restrain "treatment implications". This is both a baseline and long-term brand asset.
3. A Product Failure I Experienced (Numbers and Process)
October 2023, Shanghai. We internally tested a "Quit Smoking Companion Monthly Card": 199 yuan/month, one daily voice message + check-in. First batch of 36 seed users, from the most engaged in private domain.
Problems emerged one by one:
The review conclusion wasn't "companion has no value", but the product mechanism was wrong: we sold "we work hard to update daily", users wanted "someone/tool to catch them in the 5 minutes when impulse strikes". Later changed to:
Total human hours decreased, user completion rate and word-of-mouth went up. The essence of product design is resource allocation: use professional ability on leverage points, not performing diligence.
4. Connection with Product Sales
If the account eventually leads to devices, consumables, replacement products (requiring qualifications and compliance), the science account's most common mistake is: the content talks science, the detail page talks parameters, with no "usage narrative" in between.
Users won't automatically understand "why this form suits me — a pack-a-day smoker with cravings on the commute subway" just because you explained nicotine receptors clearly. What's needed:
The professional account's greatest advantage in products is credible limitation statements. Those who dare to clearly state boundaries are more suited for this track's long-term business than those who only pile on efficacy claims.
IV. Turning the Three Knives into Actionable Self-Check
If you're also a tobacco/quit-science account that "looks professional but has a quiet wallet", I suggest making changes in this order, not running ten projects in parallel:
This week: Only positioning
1. Count your last 30 pieces: harm mechanisms vs process methods vs product scenarios — is the ratio heavily skewed to the first?
2. Sample 100 comments, tag "curious onlooker / currently quitting / helping family". If "currently quitting" is below 20%, positioning is almost certainly off.
3. Rewrite the account's one-liner: must include crowd state + time window + result type you provide (path/tool/companion), not just "tobacco science knowledge".
Next week: Only conversion path
1. Pick one process-oriented content piece, add "free checklist/list" hook, connect to private domain or form.
2. Design 72-hour private domain three-step message, avoid pushing high-ticket on day one.
3. Make commercial identity public: bio and pinned post clearly state whether you provide tools/services, no underground conversion.
Third week: Only product
1. Remove or stop updating any "big comprehensive harm course".
2. Launch a small scene-level product around 20 yuan, targeting one high-pain moment (relapse impulse, day 3 meltdown, drinking session).
3. Use a small sample of 30 orders to see: refund rate, whether you get called "cash-grabber", whether anyone asks for next steps — then decide on 7-day camp or consultation.
My Final Personal Stance
Tobacco science accounts rarely fail to make money because "fans are too smart to pay". More commonly:
Professionalism is the entry ticket, not the business model.
In this track, I believe more in a simple model: clear-state person × short-path next step × scene-level purchasable solution.
You explain things correctly — that deserves respect. But if you want to survive, you need to turn "correct" into "usable right now", and then into "worth paying for specific help". Missing any link in between, the backend will keep looking beautiful, and the account will keep being quiet.